Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Mar 7;23(1):52.
doi: 10.1186/s12931-022-01957-3.

Association of body mass index and COPD exacerbation among patients with chronic bronchitis

Sun Hye Shin #  1 , Sung Ok Kwon #  2 , Victor Kim  3 , Edwin Kepner Silverman  4 , Tae-Hyung Kim  5 , Deog Kyeom Kim  6 , Yong Il Hwang  7 , Kwang Ha Yoo  8 , Woo Jin Kim #  9 , Hye Yun Park #  10
Affiliations
Observational Study

Association of body mass index and COPD exacerbation among patients with chronic bronchitis

Sun Hye Shin et al. Respir Res. .

Abstract

Background and objective: Chronic obstructive pulmonary disease (COPD) patients with a body mass index (BMI) < 25 kg/m2 are prone to develop adverse event of pharmacological treatment for frequent exacerbation. As chronic bronchitis (CB) is one of the strong risk factors of exacerbation, we investigated the associations between BMI and COPD exacerbations in patients with CB.

Methods: Patients with COPD were included from the Korean COPD Subgroup Study (KOCOSS), a multicenter observational cohort study. CB was defined using the St. George's Respiratory Questionnaire and the participants were categorized according to BMI cut-off of 25 kg/m2. Exacerbations during a 1-year follow-up were compared among four groups: non-CB with BMI ≥ 25 kg/m2, non-CB with BMI < 25 kg/m2, CB with BMI ≥ 25 kg/m2, and CB with BMI < 25 kg/m2.

Results: Among the 1264 patients with COPD, 451 (35.7%) had CB and 353 (27.9%) had both CB and BMI < 25 kg/m2. The COPD exacerbation risk increased across the non-CB with BMI < 25 kg/m2, CB with BMI ≥ 25 kg/m2, and CB with BMI < 25 kg/m2 groups (adjusted incidence rate ratio [95% confidence interval] 1.21 [0.89-1.62], 1.20 [0.77-1.88], and 1.41 [1.02-1.91], respectively, compared to the non-CB with BMI ≥ 25 kg/m2 group).

Conclusions: COPD patients having both CB and a BMI < 25 kg/m2 are at higher risk of exacerbations. Considering that a BMI < 25 kg/m2 often limits treatment options preventing exacerbations, modified guidelines might be needed for non-obese CB patients in Asia.

Keywords: Body mass index; COPD; Chronic bronchitis; Exacerbation.

PubMed Disclaimer

Conflict of interest statement

None of the authors has a financial relationship with a commercial entity that has an interest in the subject of this manuscript.

Figures

Fig. 1
Fig. 1
Flow diagram of the study population. *There were no missing values in BMI. BMI, body mass index; CB, chronic bronchitis; KOCOSS, Korean COPD Subgroup Study; SGRQ, St. George’s Respiratory Questionnaire
Fig. 2
Fig. 2
Distribution of patients according to the presence of chronic bronchitis and BMI categories. BMI, body mass index; CB, chronic bronchitis; KOCOSS, Korean COPD Subgroup Study
See this image and copyright information in PMC

References

    1. Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax. 2002;57:847–852. - PMC - PubMed
    1. Spencer S, Calverley PM, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23:698–702. - PubMed
    1. Hoogendoorn M, Hoogenveen RT, Rutten-van Molken MP, Vestbo J, Feenstra TL. Case fatality of COPD exacerbations: a meta-analysis and statistical modelling approach. Eur Respir J. 2011;37:508–515. - PubMed
    1. Hurst JR, Vestbo J, Anzueto A, Locantore N, Mullerova H, Tal-Singer R, et al. Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med. 2010;363:1128–1138. - PubMed
    1. Mullerova H, Maselli DJ, Locantore N, Vestbo J, Hurst JR, Wedzicha JA, et al. Hospitalized exacerbations of COPD: risk factors and outcomes in the ECLIPSE cohort. Chest. 2015;147:999–1007. - PubMed

Publication types

MeSH terms